Literature DB >> 2849056

The treatment of aspergillosis and aspergilloma with itraconazole, clinical results of an open international study (1982-1987).

K De Beule, P De Doncker, G Cauwenbergh, M Koster, R Legendre, N Blatchford, J Daunas, E Chwetzoff.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2849056     DOI: 10.1111/j.1439-0507.1988.tb03653.x

Source DB:  PubMed          Journal:  Mycoses        ISSN: 0933-7407            Impact factor:   4.377


× No keyword cloud information.
  24 in total

Review 1.  Nasal-pulmonary relations in allergic fungal sinusitis and allergic bronchopulmonary aspergillosis.

Authors:  C T Leonard; G J Berry; S J Ruoss
Journal:  Clin Rev Allergy Immunol       Date:  2001-08       Impact factor: 8.667

2.  Possible failure of itraconazole in preventing fungal infection in a neutropenic leukaemia patient.

Authors:  W D Hendriks; W Sizoo
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-02       Impact factor: 3.267

Review 3.  Antifungal treatment strategy in leukemia patients.

Authors:  T Büchner; N Roos
Journal:  Ann Hematol       Date:  1992-10       Impact factor: 3.673

4.  Systemic antifungal agents.

Authors:  L O Gentry
Journal:  Tex Heart Inst J       Date:  1990

Review 5.  Adverse effects of antifungal therapies in invasive fungal infections: review and meta-analysis.

Authors:  S B Girois; F Chapuis; E Decullier; B G P Revol
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2006-02       Impact factor: 3.267

Review 6.  Adverse effects of antifungal therapies in invasive fungal infections: review and meta-analysis.

Authors:  S B Girois; F Chapuis; E Decullier; B G P Revol
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-02       Impact factor: 3.267

Review 7.  Aspergillus lung disease in patients with sarcoidosis: a case series and review of the literature.

Authors:  Tahuanty A Pena; Ayman O Soubani; Lobelia Samavati
Journal:  Lung       Date:  2011-02-13       Impact factor: 2.584

8.  Chronic necrotising pulmonary aspergillosis treated with itraconazole.

Authors:  J A Elliott; L J Milne; D Cumming
Journal:  Thorax       Date:  1989-10       Impact factor: 9.139

9.  Primary lymph node invasive aspergillosis.

Authors:  A Mazzoni; M Ferrarese; R Manfredi; A Facchini; C Sturani; A Nanetti
Journal:  Infection       Date:  1996 Jan-Feb       Impact factor: 3.553

10.  Syndrome of the anterior spinal artery as the primary manifestation of aspergillosis.

Authors:  B Pfausler; A Kampfl; K Berek; H Maier; F Aichner; E Schmutzhard
Journal:  Infection       Date:  1995 Jul-Aug       Impact factor: 3.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.